We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name	econda
Purpose	Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

Statistics enable/disable

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name	econda
Purpose	Statistics

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

Immune Monitoring Unit

Prof. Dr. Michael Platten

Analysis of active and tumor-specific T cells via ELISpot assay.
© dkfz.de

The Immune Monitoring Unit accompanies oncological trials (IITs or industry-sponsored trials) of all phases using various immunological analysis techniques. We accompany you from the idea of a study to the final report or publication. With the help of state-of-the-art analyzes and proven analyzes, we can study the sample material as best as possible. Our employees are constantly upskilled to incorporate the latest research findings into analyzes. Standardized work according to SOPs makes our evaluations comparable. Please don’t hesitate to contact us.

Contact

Prof. Dr. Michael Platten

Immune Monitoring Unit (G808)

Deutsches Krebsforschungszentrum

und Nationales Centrum für Tumorerkrankungen (NCT)
Im Neuenheimer Feld 460

69120 Heidelberg

Contact:
Dr. Isabel Poschke
Tel: +49 6221-56-35210
E-Mail: i.poschke@dkfz.de

Selected Publications

Grassl N, Poschke I, Lindner K, Bunse L, Mildenberger I, Boschert T, Jähne K, Green EW, Hülsmeyer I, Jünger S, Kessler T, Suwala AK, Eisele P, Breckwoldt MO, Vajkoczy P, Grauer OM, Herrlinger U, Tonn JC, Denk M, Sahm F, Bendszus M, von Deimling A, Winkler F, Wick W, Platten M, Sahm K. A H3K27M-targeted vaccine in adults with diffuse midline glioma. Nat Med. 2023 Oct;29 PMID:37735561
Platten M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F, Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA, Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP, Bendszus M, von Deimling A, Schmitt M, Wick W. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021 Apr;592(7854):463-468.